At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Special Drug Use Surveillance; AZILVA Tablets and AZILVA Granules 1% in Pediatric Use
In Brief
An observational study evaluating Azilsartan (TAK-536) for Hypertension. Completed, enrolled 5 participants across 1 site.
Detailed Summary
The main aim of this study is to check for side effects from treatment with azilsartan and how well azilsartan controls blood pressure in children from 6 to less than 16 years old with high blood pressure. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study. During the study, participants with high blood pressure will take azilsartan tablets or azilsartan granules once a day according to their clinic's standard practice. The study doctors will check for side effects from azilsartan for up to 12 months after treatment starts.
Study Details
Timeline
Interventions
Azilsartan Tablets, Azilsartan Granules